https://www.selleckchem.com/products/ABT-263.html
617-2.105, p less then 0.001). With the exception of hyperlipidemia, most comorbidities correlated with an increased risk of CKD. Persistent use of sleeping pills after CKD diagnosis increased the risk of concurrent ESRD (aHR = 7.542; 95% CI 4.267-10.156; p less then 0.001). After the subgroup analysis for sleeping pill use, brotizolam (p = 0.046), chlordiazepoxide (p less then 0.001), clonazepam (p less then 0.001), diazepam (p less then 0.001), dormicum (p less then 0.001), estazolam (p less then 0.001), fludiazepam (p less then 0.001
Like
Comment
Share
